These articles are written from observed patient patterns, not textbook summaries. Each one addresses a question that recurring HS patients ask — after everything else has failed to explain why.
HS rarely stays at its presenting stage. It evolves — from isolated nodules to recurrent abscesses, from abscesses to tunnels, from tunnels to fibrosis. Understanding this trajectory matters because it changes how intervention is approached at every stage.
Read Full Article →A detailed look at the progression trajectory of HS and why early intervention changes long-term outcomes dramatically.
Why treating inflammation alone misses the point, and what drives the inflammatory process from within in HS patients.
When antibiotic courses become longer and more frequent, it usually means the disease is progressing, not being controlled.
Why treatment sequence matters more than treatment intensity — and why most approaches begin at the wrong layer.
Reversal in HS is not a single event. It is a process of system stabilisation that unfolds across multiple stages.
The skin lesion is not the disease. Understanding what internal state it reflects changes how the condition is approached entirely.
Explains the gut–skin axis and why gut dysfunction is a primary driver in most HS patients — not a secondary concern.
Aggressive interventions can disrupt the internal environment further. Why the pace of correction matters as much as the direction.
What the actual recovery trajectory looks like from observed patient patterns — and why early improvements are not always visible.
Why the pattern of flares is more informative than the flares themselves — and what stability really means in HS management.
The case for understanding HS as a whole-body inflammatory state, not a localised skin condition with occasional flares.
What happens when gut function, immune regulation, hormonal balance, and skin integrity all begin to drift simultaneously.
A structured look at how Ayurvedic clinical thinking maps onto the known stages of HS progression — and what it adds to the picture.
Understanding why Ayurvedic medicine classifies long-standing HS differently — and why that classification changes the treatment approach.
How long-term metabolic dysfunction creates a physiological "memory" that keeps driving HS recurrence even after surface lesions resolve.
The role of lifestyle in HS is real but often misunderstood. What it can and cannot do in the absence of internal correction.
HS is not one disease with one mechanism. The variation in treatment response reflects variation in the underlying drivers.
Why localised circulation matters in HS — and how microvascular damage in recurrent zones slows healing and promotes scarring.
Two different states that look similar on the surface but require completely different approaches in clinical management.
An honest look at patient profiles, disease stages, and internal factors that influence how and when someone responds to structured treatment.
An honest clinical perspective on when Ayurvedic approaches are insufficient — and what determines the boundary between manageable and not.
Why patients who achieve lasting improvement consistently describe a shift in how they engage with treatment — not just which treatment they choose.
When flares appear controlled but tissue damage continues accumulating underneath — and the clinical signs that distinguish the two states.
The same intervention produces different results in different patients because tissue responsiveness is not uniform — and it can be addressed.
For patients on long-term antibiotics or biologics, the sequence of reduction matters as much as the decision to reduce.
"When a condition keeps recurring, it usually follows an underlying pattern that needs to be understood and addressed — not suppressed."
— EPOH Clinical FrameworkIf your HS keeps recurring despite treatment, the articles here explain why that happens. A structured evaluation identifies which internal factors are active in your specific case.